EULAR recommendations underplay importance of severe anxiety and depression in fibromyalgia treatment

Annals of the Rheumatic Diseases

Volumn 76, Issue 12, 2017, Pages

  Mercieca, Cecilia ^a   Borg, Andrew A ^a  

^a MATER DEI HOSPITAL   (Malta)

Author keywords

Fibromyalgis Pain Syndromes; Multidisciplinary team care; Psychology

Indexed keywords

AGE DISTRIBUTION; ANXIETY; CHRONIC PAIN; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; EMPLOYMENT STATUS; FATIGUE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; KINESIOTHERAPY; LETTER; PAIN ASSESSMENT; PATIENT DECISION MAKING; PATIENT SATISFACTION; SYMPTOM SEVERITY SCORE; TIME TO TREATMENT; TREATMENT PLANNING; VISUAL ANALOG SCALE; WIDESPREAD PAIN INDEX; ANXIETY DISORDER;

ANXIETY; ANXIETY DISORDERS; DEPRESSION; DEPRESSIVE DISORDER; FIBROMYALGIA; HUMANS;

EID: 85036560705     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2017-211573     Document Type: Letter

References (2)

1. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of Fibromyalgia. Ann Rheum Dis 2017;76:318-28.
2. Jensen KB, Petzke F, Carville S, et al. Anxiety and depressive symptoms in Fibromyalgia are related to poor perception of health but not to pain sensitivity or cerebral processing of pain. Arthritis Rheum 2010;62:3488-95.